Diabetes Care, Vol 21, Issue 2 291-295, Copyright © 1998 by American Diabetes Association

ARTICLES

The association between diabetic complications and exercise capacity in NIDDM patients

RO Estacio, JG Regensteiner, EE Wolfel, B Jeffers, M Dickenson and RW Schrier
Department of Medicine, Denver Health and University of Colorado Health Sciences Center, Colorado 80262, USA.

OBJECTIVE: Exercise capacity has been used as a noninvasive parameter for predicting cardiovascular events. It has been demonstrated previously in NIDDM patients that several risk factors (i.e., obesity, smoking, hypertension, and African-American race) are associated with an impaired exercise capacity. We studied 265 male and 154 female NIDDM patients who underwent graded exercise testing with expired gas analyses to determine the possible influences of diabetic neuropathy, nephropathy, and retinopathy on exercise capacity. RESEARCH DESIGN AND METHODS: Univariate and multiple linear regression analyses were performed to determine the relationship between diabetic neuropathy, urinary albumin excretion (UAE), and retinopathy with respect to peak oxygen consumption (VO2). Neuropathy was assessed by neurological symptom and disability scores, autonomic function testing, and quantitative sensory exams involving thermal and vibratory sensation. Three categories of UAE were used: normal albuminuria (< 20 micrograms/min), microalbuminuria (20-200 micrograms/min), and overt albuminuria (> 200 micrograms/min). Retinopathy was assessed by stereoscopic fundus photographs. Multiple linear regression analyses were then performed controlling for age, sex, length of diagnosed diabetes, duration of hypertension, race and ethnicity, GHb, BMI, and smoking to determine whether there was an independent effect of these diabetic complications on exercise capacity. RESULTS: Univariate analyses revealed that the presence of diabetic retinopathy (P = 0.03), neuropathy (P = 0.002), microalbuminuria (P = 0.04), and overt albuminuria (P = 0.06) were associated with a lower peak VO2. Multiple linear regression analyses were performed to determine independent relationships with peak VO2. The results revealed that increasing retinopathy stage (Parameter estimate [PE] = -0.59 +/- 0.3 ml.kg-1.min-1; P = 0.026) and increasing UAE stage (PE = -0.62 +/- 0.3 ml.kg-1.min-1; P = 0.04) were associated with a decrease in peak VO2. CONCLUSIONS: In the present study of NIDDM subjects, a significant independent association was demonstrated between diabetic nephropathy and retinopathy with exercise capacity. These results were obtained controlling for age, sex, length of diagnosed diabetes, hypertension, race, and BMI. Thus the findings in this large NIDDM population without a history of coronary artery disease indicate a potential pathogenic relationship between microvascular disease and exercise capacity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. L Marcus, S. Smith, G. Morrell, O. Addison, L. E Dibble, D. Wahoff-Stice, and P. C LaStayo Comparison of Combined Aerobic and High-Force Eccentric Resistance Exercise With Aerobic Exercise Only for People With Type 2 Diabetes Mellitus Physical Therapy, November 1, 2008; 88(11): 1345 - 1354. [Abstract] [Full Text] [PDF]

				M. G. Clark Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E732 - E750. [Abstract] [Full Text] [PDF]

				S. F. E. Praet and L. J. C. van Loon Optimizing the therapeutic benefits of exercise in Type 2 diabetes J Appl Physiol, October 1, 2007; 103(4): 1113 - 1120. [Abstract] [Full Text] [PDF]

				E. R. Mohler III, G. Lech, G. E. Supple, H. Wang, and B. Chance Impaired Exercise-Induced Blood Volume in Type 2 Diabetes With or Without Peripheral Arterial Disease Measured by Continuous-Wave Near-Infrared Spectroscopy Diabetes Care, August 1, 2006; 29(8): 1856 - 1859. [Abstract] [Full Text] [PDF]

				A. S. Tibb, P. V. Ennezat, J. A. Chen, A. Haider, S. Gundewar, V. Cotarlan, V. S. Aggarwal, A. Talreja, and T. H. Le Jemtel Diabetes Lowers Aerobic Capacity in Heart Failure J. Am. Coll. Cardiol., September 6, 2005; 46(5): 930 - 931. [Full Text] [PDF]

				A. C.-W. Lau, M. K.-W. Lo, G. T.-C. Leung, F. P.-T. Choi, L. Y.-C. Yam, and K. Wasserman Altered Exercise Gas Exchange as Related to Microalbuminuria in Type 2 Diabetic Patients Chest, April 1, 2004; 125(4): 1292 - 1298. [Abstract] [Full Text] [PDF]

				M. Scheuermann-Freestone, P. L. Madsen, D. Manners, A. M. Blamire, R. E. Buckingham, P. Styles, G. K. Radda, S. Neubauer, and K. Clarke Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes Circulation, June 24, 2003; 107(24): 3040 - 3046. [Abstract] [Full Text] [PDF]

				B. A. Kingwell, M. Formosa, M. Muhlmann, S. J. Bradley, and G. K. McConell Type 2 Diabetic Individuals Have Impaired Leg Blood Flow Responses to Exercise: Role of endothelium-dependent vasodilation Diabetes Care, March 1, 2003; 26(3): 899 - 904. [Abstract] [Full Text] [PDF]

				J. C. Baldi, J. L. Aoina, H. C. Oxenham, W. Bagg, and R. N. Doughty Reduced exercise arteriovenous O2 difference in Type 2 diabetes J Appl Physiol, March 1, 2003; 94(3): 1033 - 1038. [Abstract] [Full Text] [PDF]

				K. J. Stewart Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health JAMA, October 2, 2002; 288(13): 1622 - 1631. [Abstract] [Full Text] [PDF]